Xeris Biopharma Holdings Inc (STU:2B30)
€ 7.23 +0.11 (+1.49%) Market Cap: 1.25 Bil Enterprise Value: 1.38 Bil PE Ratio: 137.83 PB Ratio: 110.27 GF Score: 74/100

Q1 2026 Xeris Biopharma Holdings Inc Earnings Call Transcript

May 7, 2026 / 12:30 PM GMT
Release Date Price: €5.61 (+3.66%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

XERS.OQ - Xeris Biopharma Holdings Inc
Q1 2026 Xeris Biopharma Holdings Inc Earnings Call
May 07, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, and welcome to the Zaris Biopharma Q1-26 Earnings Conference Call.

Please note that before we begin, this conference is being recorded on Thursday, May 7th at 8:30 a.m.

I will now pass the call over to Allison Wei for opening remarks. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Sarah. Good morning, everyone, and welcome to Zaris's first quarter financial results conference call.

Earlier this morning, we issued a press release detailing our first quarter 2026 financial and operating results.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot